New pill aims to tame rare mast cell disease
NCT ID NCT04910685
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental drug called elenestinib (BLU-263) in people with indolent systemic mastocytosis, a rare condition where too many mast cells cause symptoms like flushing, itching, and stomach issues. About 534 participants will receive either the drug or a placebo, plus standard symptom treatments. The goal is to see if elenestinib can better control symptoms that aren't helped by current therapies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Elenestinib (also called BLU-263), an oral tablet
- What this could lead to
- If it works, this could offer a new treatment option for people with indolent systemic mastocytosis whose symptoms are not controlled by current therapies.
- What could go wrong
- This is an early-to-mid-stage trial, so results are uncertain. The drug may cause side effects or fail to improve symptoms better than placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INDOLENT SYSTEMIC MASTOCYTOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AOU Policlinico G.Rodolico - San Marco
RECRUITINGCatania, 95123, Italy
-
Brigham and Women's Hospital
RECRUITINGBoston, Massachusetts, 02115, United States
-
CHP Centro Hematologico Pavlovsky
RECRUITINGBuenos Aires, 1113, Argentina
-
CHU Amiens-Picardie
RECRUITINGAmiens, 80000, France
-
CHU Grenoble
RECRUITINGGrenoble, 38043, France
-
CHU Tivoli
RECRUITINGLa Louvière, 7100, Belgium
-
CHU Toulouse - Hopital Larrey
RECRUITINGToulouse, France
-
CHU de Caen
RECRUITINGCaen, France
-
CHU de Limoges
RECRUITINGLimoges, 87042, France
-
CHU de Nantes
RECRUITINGNantes, 44093, France
-
CHU de Poitiers
RECRUITINGPoitiers, 86000, France
-
CHUPorto, EPE - Hospital de Santo António
RECRUITINGPorto, 4099-001, Portugal
-
Cancer and Haematology Centre
RECRUITINGOxford, OX3 7LE, United Kingdom
-
Centro Hospitalar Universitario Sao Joao, E.P.E.
RECRUITINGPorto, 4200-139, Portugal
-
Centro Hospitalar de Lisboa Central, E.P.E. - Hospital de Santo Antonio dos Capuchos
RECRUITINGLisbon, 1169-050, Portugal
-
Charité - Universitätsmedizin Berlin Institute of Allergology
RECRUITINGBerlin, 12203, Germany
-
Columbia University Medical Center
RECRUITINGNew York, New York, 10032, United States
-
Consultorios Medicos Dr. Doreski - Fundacion Respirar
RECRUITINGBuenos Aires, 1426, Argentina
-
Cork University Hospital
RECRUITINGCork, T12 DC4A, Ireland
-
David Geffen School of Medicine at UCLA
RECRUITINGLos Angeles, California, 90095, United States
-
Duke Asthma, Allergy and Airway Center
RECRUITINGDurham, North Carolina, 27705, United States
-
ErasmusMC
RECRUITINGRotterdam, South Holland, 3015 GD, Netherlands
-
Fakultní nemocnice Brno, Interní hematologická a onkologická klinika
RECRUITINGBrno, 625 00, Czechia
-
Fakultní nemocnice Královské Vinohrady, Hematologická klinika 3. LF UK v Praze a FNKV
RECRUITINGPrague, 100 34, Czechia
-
General Hospital of Thessaloniki "G. Papanikolaou"
RECRUITINGThessaloniki, 57010, Greece
-
Guy's and St Thomas's NHS Foundation Trust
RECRUITINGLondon, SE1 7EH, United Kingdom
-
Hospital Universitario Ramon y Cajal
RECRUITINGMadrid, 28034, Spain
-
Hospital Universitario Vall d'Hebron
RECRUITINGBarcelona, Spain
-
Hospital Virgen del Valle - Instituto de Estudios de Mastocitosis de Castilla-La Mancha
RECRUITINGToledo, 45071, Spain
-
Hospital das Clínicas da Faculdade de Medicina da USP - HCFMUSP
RECRUITINGSão Paulo, 05403-010, Brazil
-
Huntsman Cancer Institute, University of Utah
RECRUITINGSalt Lake City, Utah, 84112, United States
-
Hôpital Necker - Départementd 'HématologieA dultes
RECRUITINGParis, 75015, France
-
Hôpital de la Pitié Salpétrière
RECRUITINGParis, 75013, France
-
Kepler Universitatsklinikum, Med Campus III. Clinic of Internal Medicine 3 - Hematology and Oncology
RECRUITINGLinz, 4021, Austria
-
LMU Klinikum
RECRUITINGMunich, 80377, Germany
-
Luzerner Kantonsspital
RECRUITINGLucerne, 6000, Switzerland
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55902, United States
-
Mersin VM Medikal Park Hastanesi
RECRUITINGMersin, 33200, Turkey (Türkiye)
-
Michigan Medicine University of Michigan
RECRUITINGAnn Arbor, Michigan, 48109, United States
-
Oslo University Hospital
RECRUITINGOslo, N-0424, Norway
-
Princess Alexandra Hospital
RECRUITINGWoolloongabba, Queensland, Australia
-
Roswell Park Cancer Institute
RECRUITINGBuffalo, New York, 14263, United States
-
S.C. Ematologia Fondazione I.R.C.C.S. Policlinico San Matteo
RECRUITINGPavia, 27100, Italy
-
S.S.D. Immunologia Clinica e Allergologia Azienda Ospedaliera Universitaria San Giovanni di Dio e Ruggi d'Aragona
RECRUITINGSalerno, 84131, Italy
-
SOD Ematologia (Ambulatori)- AOUC Azienda Ospedaliero Universitaria Careggi
RECRUITINGFlorence, Tuscany, 50134, Italy
-
Stanford Cancer Institute
RECRUITINGPalo Alto, California, 94305, United States
-
The Alfred Hospital
RECRUITINGMelbourne, Victoria, 3004, Australia
-
The University of Texas, MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
UCHealth Blood Disorders and Cell Therapies Center - Anschutz Medical Campus
RECRUITINGAurora, Colorado, 80045, United States
-
UOC Ematologia
RECRUITINGMilan, Lombardy, 20122, Italy
-
Unita Operativa di Ematologia AOU Policlinico S. Orsola-Malpighi
RECRUITINGBologna, 40138, Italy
-
Unitversitair Ziekenhuis Antwerpen
RECRUITINGEdegem, Antwerpen, Belgium
-
Unità Operativa di Allergologia Azienda Ospedaliera Universitaria Integrata di Verona
RECRUITINGVerona, 37126, Italy
-
Universitair Ziekenhuis Gent
RECRUITINGGhent, 9000, Belgium
-
University Clinic Erlangen
RECRUITINGErlangen, 91054, Germany
-
University Clinic Hamburg Eppendorf
RECRUITINGHamburg, 20246, Germany
-
University College London Hospitals (UCLH), Haematology Cancer Clinical Trials Unit
RECRUITINGLondon, NW1 2PG, United Kingdom
-
University General Hospital - General Hospital of West Attica
RECRUITINGChaïdári, 12462, Greece
-
University Hospital Basel
RECRUITINGBasel, C-4031, Switzerland
-
University Hospital Plymouth NHS Trust
RECRUITINGPlymouth, PL6 8DH, United Kingdom
-
University Hospital of Wales
RECRUITINGCardiff, Wales, CF14 4XW, United Kingdom
-
University Hospital of Wales
RECRUITINGCardiff, CF14 4XW, United Kingdom
-
University Medical Center Groningen
RECRUITINGGroningen, 9713 GZ, Netherlands
-
University of Alabama at Birmingham
RECRUITINGBirmingham, Alabama, 35294, United States
-
University of Cincinnati Medical Center
RECRUITINGCincinnati, Ohio, 45219, United States
-
Universitätsklinikum RWTH Aachen Klinik für Hämatologie, Onkologie, Hämostaseologie und Stammzelltransplantation
RECRUITINGAachen, Germany
-
Universitätsmedizin Mannheim III. Medizinische Klinik Universität Heidelberg Medizinische Fakultät Mannheim
RECRUITINGMannheim, 68167, Germany
-
Uniwersyteckie Centrum Kliniczne Klinika Alergologii
RECRUITINGGdansk, 80-214, Poland
-
Uppsala University Hospital
RECRUITINGUppsala, 751 85, Sweden
-
Winship Cancer Institute, Emory University
RECRUITINGAtlanta, Georgia, 30322, United States
-
lstanbul Universitesi lstanbul Tip Fakultesi Hastanesi
RECRUITINGIstanbul, 34093, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New study tracks daily life with rare mast cell disorder
- New drug avapritinib under Real-World watch for mastocytosis relief
- New drug aims to ease symptoms of rare mast cell disease
- New hope for mastocytosis patients: expanded access to bezuclastinib
- New drug aims to ease daily misery of rare mast cell disease